Comparable observations have been made in models of acute kidney injury, diabetic retinopathy, rheumatoid arthritis, or sickle cell disease, where loss of ADAMTS13 increased inflammation, and recombinant ADAMTS13 exerted anti-inflammatory effects [42,60,61,62]. This evidence concerns the gene ADAMTS13 and sickle cell disease.